NO307518B1 - Terapeutisk aktiv forbindelse til behandling av kognitive mangler og smerte - Google Patents

Terapeutisk aktiv forbindelse til behandling av kognitive mangler og smerte

Info

Publication number
NO307518B1
NO307518B1 NO950053A NO950053A NO307518B1 NO 307518 B1 NO307518 B1 NO 307518B1 NO 950053 A NO950053 A NO 950053A NO 950053 A NO950053 A NO 950053A NO 307518 B1 NO307518 B1 NO 307518B1
Authority
NO
Norway
Prior art keywords
pain
treatment
active compound
therapeutically active
cognitive deficits
Prior art date
Application number
NO950053A
Other languages
English (en)
Norwegian (no)
Other versions
NO950053L (no
NO950053D0 (no
Inventor
Alessandro Bartolini
Carla Ghelardini
Alberto Giotti
Fulvio Gualtieri
Serena Scapecchi
Gino Toffano
Original Assignee
Abiogen Pharma Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abiogen Pharma Srl filed Critical Abiogen Pharma Srl
Publication of NO950053L publication Critical patent/NO950053L/no
Publication of NO950053D0 publication Critical patent/NO950053D0/no
Publication of NO307518B1 publication Critical patent/NO307518B1/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D451/00Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • C07D451/04Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D451/00Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • C07D451/04Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
    • C07D451/06Oxygen atoms
    • C07D451/10Oxygen atoms acylated by aliphatic or araliphatic carboxylic acids, e.g. atropine, scopolamine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO950053A 1992-07-08 1995-01-06 Terapeutisk aktiv forbindelse til behandling av kognitive mangler og smerte NO307518B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITMI921659A IT1255323B (it) 1992-07-08 1992-07-08 Composti ad attivita' analgesica e nootropa
PCT/EP1993/001743 WO1994001435A1 (en) 1992-07-08 1993-07-06 New analgesic and nootropic drugs

Publications (3)

Publication Number Publication Date
NO950053L NO950053L (no) 1995-01-06
NO950053D0 NO950053D0 (no) 1995-01-06
NO307518B1 true NO307518B1 (no) 2000-04-17

Family

ID=11363636

Family Applications (1)

Application Number Title Priority Date Filing Date
NO950053A NO307518B1 (no) 1992-07-08 1995-01-06 Terapeutisk aktiv forbindelse til behandling av kognitive mangler og smerte

Country Status (14)

Country Link
US (1) US5583142A (it)
EP (1) EP0650486A1 (it)
JP (1) JPH07508739A (it)
KR (1) KR100258336B1 (it)
AU (1) AU4564593A (it)
CA (1) CA2139739A1 (it)
CZ (1) CZ2295A3 (it)
FI (1) FI950029A (it)
HU (1) HUT73481A (it)
IT (1) IT1255323B (it)
NO (1) NO307518B1 (it)
RU (1) RU95105457A (it)
SK (1) SK1895A3 (it)
WO (1) WO1994001435A1 (it)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5794887A (en) 1995-11-17 1998-08-18 Komerath; Narayanan M. Stagnation point vortex controller
EP2206712A1 (en) * 2008-12-23 2010-07-14 CHIESI FARMACEUTICI S.p.A. "Alkaloid aminoester derivatives and medicinal composition thereof"
RU2744571C1 (ru) * 2020-04-10 2021-03-11 Общество с ограниченной ответственностью "ВладМиВа"(ООО "ВладМиВа") Дифармакофорные соединения ноотропно-анальгетического действия и способ их получения

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1289429A (fr) * 1960-03-10 1962-04-06 Lepetit Spa Procédé de préparation des nouveaux esters de la tropine
DE1670142A1 (de) * 1966-09-02 1970-07-16 Boehringer Sohn Ingelheim Verfahren zur Herstellung von Atropin,Scopolamin und deren N-substituierten Derivaten
DE4108393A1 (de) * 1991-03-15 1992-09-17 Boehringer Ingelheim Kg Neue ester bi- und tricyclischer aminoalkohole, ihre herstellung und ihre verwendung in arzneimitteln

Also Published As

Publication number Publication date
RU95105457A (ru) 1997-05-10
FI950029A (fi) 1995-03-06
JPH07508739A (ja) 1995-09-28
NO950053L (no) 1995-01-06
EP0650486A1 (en) 1995-05-03
ITMI921659A0 (it) 1992-07-08
SK1895A3 (en) 1995-07-11
ITMI921659A1 (it) 1994-01-08
HU9403797D0 (en) 1995-02-28
FI950029A0 (fi) 1995-01-03
CA2139739A1 (en) 1994-01-20
IT1255323B (it) 1995-10-31
WO1994001435A1 (en) 1994-01-20
HUT73481A (en) 1996-08-28
NO950053D0 (no) 1995-01-06
AU4564593A (en) 1994-01-31
KR100258336B1 (ko) 2000-08-01
US5583142A (en) 1996-12-10
KR950702557A (ko) 1995-07-29
CZ2295A3 (en) 1996-02-14

Similar Documents

Publication Publication Date Title
NO934547D0 (no) Oral behandling av Helicobacter-in-feksjon
DE69315257D1 (de) Simethicon enthaltende Arzneimittel zur Behandlung gastrointestinaler Störungen
NO982172D0 (no) Anvendelse av epinastin for behandling av smerter
ATE275383T1 (de) Oxadisäuren und verwandte verbindungen zur behandlung von hautstörungen
NO976063D0 (no) Fremgangsmåte for behandling av diabetes
HUP9904361A3 (en) Use of isobutylgaba and its derivatives for the treatment of pain
NO990433D0 (no) Nye forbindelser og blandinger for behandling av sykdommer i forbindelse med tryptase-aktivitet
NO920780L (no) Fremgangsmaate og anordning for behandling av epilepsi
DK64592D0 (da) Peptider til terapeutisk behandling
DE69532066D1 (de) Arzneimittel zur Behandlung von Restenosis und Gefässsklerose
NO20014674L (no) Fremgangsmåte for behandling av neurologiske og neuropsykiatriske forstyrrelser
DE69620691D1 (de) Therapeutisches Mittel zur Behandlung der Hypercholesterinämie
NO991459D0 (no) Anvendelse av 1-hydroksy-2-pyridoner til behandling av hudinfeksjoner
NO970198D0 (no) Anvendelse av glyceryltriacetat for behandling av onychomykoser
NO983465D0 (no) Farmas°ytisk kombinasjonspreparater inneholdende LHRH-analoger og anti°strogener for behandling av gynekologiske forstyrrelser
NO961226L (no) Blandinger for forebyggelse og behandling av viralinduserte tumorer
NO995231D0 (no) Terapeutisk behandling av hudlidelser
NO984432L (no) FremgangsmÕte for behandling av migrenesmerte
NO307518B1 (no) Terapeutisk aktiv forbindelse til behandling av kognitive mangler og smerte
NO982562D0 (no) Sammensetning for behandling av smerte
NO973366D0 (no) Fremgangsmåte for behandling av multippel sklerose
DE69737088D1 (de) Therapeutisches agens zur behandlung von fiv infektionen
NO930758D0 (no) Anordning for haandtering av roer
NO951932L (no) Behandling av infertilitet og forökning av fertiliseringskapasiteter
NO172538C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 6-fenoksymetyl-4-hydroksytetrahydropyran-2-oner og 6-tiofen-oksymetyl-4-hydroksytetrahydropyran-2-oner

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees

Free format text: LAPSED IN JANUARY 2002